<a href="https://laohu8.com/S/PDEX">Pro-Dex</a> Inc. First Quarter Net Income Rises to $4.7 Million on $18.5 Million Sales
Pro-Dex Inc. reported net income of $4.7 million, or $1.40 per diluted share, for the quarter ended September 30, 2025, compared to $2.5 million, or $0.75 per diluted share, in the same period of the previous year. The net income for the most recent quarter includes unrealized gains on marketable equity investments of $3.3 million, compared to $433,000 in unrealized gains in the prior year's quarter. The company's investment in Monogram Technologies, Inc. was valued at the cash price received in October 2025 upon its acquisition by Zimmer Biomet Holdings, Inc., resulting in cash proceeds of $8.9 million. Operating income for the quarter increased by $0.1 million, or 3%, to $3.1 million, compared to $3.0 million in the previous year's corresponding period. Gross profit rose by $0.2 million, or 4%, while gross margin declined to 29% from 35% in the prior year, mainly due to higher costs including tariffs. Operating expenses rose by $0.1 million, or 6%, to $2.3 million, attributed primarily to increased personnel costs related to human resources, information technology, and facilities.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pro-Dex Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1093358) on October 30, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.